call Toll Free (US/Canada) : +1 866 658 6826 | call +1 425 320 4776 | call (UK) : +44 1865 60 0662 | email info(@)blueweaveconsulting.com
Home | About Us | Career | Services | Blog | Contact Us
Blueweave
Infection Surveillance Solutions Market
Inquire Before Buying Request for Sample

Infection Surveillance Solutions Market

Home ICT Infection Surveillance Solutions Market

SPECIAL OFFER : 25% Super Discount For All !

Infection Surveillance Solutions Market - Global Size, Share, Trend Analysis, Opportunity and Forecast Report, 2019–2029, Segmented By Offering (Software, Services); By Infection Type (Surgical Site Infections (SSI), Blood Stream Infections (BSI), Urinary Tract Infections (UTI)); By End Use (Long Term Care Facilities, Hospitals); By Region (North America, Europe, Asia Pacific, Latin America, Middle East and Africa)

  • Published Date: February 2023
  • Report ID: BWC23157
  • Available Format: PDF
  • Page: 400

Report Overview

Growing adoption of antimicrobial stewardship programs and rapid advancements in healthcare IT addressing infectious therapeutic segment are projected to propel the expansion of global infection surveillance solutions market during the forecast period between 2023 and 2029.

Global Infection Surveillance Solutions Market - Industry Trends & Forecast Report, 2029

Global infection surveillance solutions market size was estimated at USD 469.91 million in 2022. During the forecast period between 2023 and 2029, the size of global infection surveillance solutions market is projected to grow at a CAGR of 13.81% reaching a value of USD 1,152.12 million by 2029. Major growth drivers for global infection surveillance solutions market include growing prevalence of hospital-acquired infections (HAIs), increasing antibiotic resistance in microorganisms, and high adoption of automation in healthcare settings. The growing number of procedures conducted around the world has resulted in longer hospital stays. As a result, the number of patients suffering from HAIs is expected to rise. The increasing focus on containing HAIs and treating the patients affected by them is expected to aid the market growth. Increasing healthcare spending is also forecast to increase demand for infection surveillance technologies. Also, favorable government measures will contribute to the market expansion.

Infection Surveillance Solutions Market

Global Infection Surveillance Solutions Market – Overview

Infection monitoring software supports healthcare facilities, such as hospitals and others in reporting patient data to state and federal authorities. This program notifies hospital Internet Protocol (IPs) when an infection occurs, allowing HAI specialists and nurses to treat infected patients and prevent infection epidemics. These solutions are used to identify infections as well as to evaluate prevention actions. They are also required to avoid infections caused by sterilized medical devices and to diagnose antibiotic-resistant organisms. These systems benefit healthcare facilities by providing accurate staff health information, surgical databases, and real-time medical records. Surveillance strategies are employed to control infection patterns. The increasing analytics capabilities of IT systems is assisting the market's growth. Hospitals have emerged as the primary end-user in these sectors due to their high adoption rate for preserving electronic healthcare data and managing real-time pharmacy. Infection monitoring systems are meant to continuously monitor and analyze health-related data to ensure that preventive actions are properly applied. Hospital-acquired illnesses, also known as nosocomial infections, are caused by a variety of factors, including poor hygienic conditions, neglect, weakened patient immunity, the invasion of drug-resistant bacteria, and procedures that can reduce the effectiveness of ongoing treatments.

Global Infection Surveillance Solutions Market

Growth Drivers

Growing Adoption of Antimicrobial Stewardship Programs

Infection Control and Epidemiology are working hard to reduce the rising number of HAIs. Antimicrobial resistance (AMR) is a global danger to human health and development. AMR was named one of the top ten global public health dangers confronting humanity by the WHO. According to the WHO 2020 study, the global economic burden of AMR is enormous. Aside from mortality and incapacity, prolonged illness causes longer hospital stays, the need for more expensive drugs, and financial difficulties for those affected. In 2015, the WHO launched the global antimicrobial resistance and use surveillance system, which combined data from AMR surveillance in humans and antimicrobial drug use surveillance. GLASS offers a standardized approach to data collection, analysis, interpretation, and sharing by countries, territories, and areas, as well as monitoring the state of existing and new national surveillance systems.

Restraints

High Cost of Deployment for Small Healthcare Organizations

The rising price of interoperability and deployment makes implementing healthcare IT software solutions expensive. Smaller healthcare companies encounter difficulty in deploying internet access due to difficulties in setting up numerous networks in healthcare contexts, limited wireless possibilities, and the requirement for comprehensive security procedures to prevent data breaches. Also, infection surveillance software is costly. Furthermore, support and maintenance services, which include software modification and upgrading in response to changing user requirements, are recurring expenses that make for a significant portion of the total cost of ownership. Additionally, custom interface development for post-sales device connection necessitates additional validation and verification, increasing the total cost of ownership for healthcare providers. These additional fees are prohibitively expensive for smaller hospitals and healthcare organizations.

Impact of COVID-19 on Global Infection Surveillance Solutions Market

COVID-19 had a detrimental impact on infection surveillance solutions market. The pandemic compelled governments to invest extensively in vaccination efforts as well as hospital facilities and staffing. Yet, the global economic slump has upended government intentions to maintain or grow spending to address a backlog of non-COVID treatment and resolve staffing shortages. According to the Economist Intelligence Unit, total healthcare spending will rise by 4.9% in nominal terms in 2023, owing to higher expenses and wages. Yet, actual spending is anticipated to fall somewhat as it fails to keep up with inflation.

Global Infection Surveillance Solutions Market

Segmental Coverage

Global Infection Surveillance Solutions Market – By Offering

By offering, global infection surveillance solutions market is bifurcated into Software and Services segments. The software segment is expected to hold a higher share in global infection surveillance solutions market during the forecast period, because of the increasing use of management surveillance software. The software segment includes on-premises and web-based. During the period in analysis, the web-based software is expected to grow at a faster rate. The rise in sub-segment can be ascribed to its advantages over on-premises software, including as availability in various configurations, rapid return on investment, and real-time analysis. Furthermore, healthcare IT businesses develop unique solutions in data management, analytics, and infrastructure that facilitate the collecting of data from electronic health records (EHR), infection, and epidemic patterns via their software packages.

Infection Surveillance Solutions Market Share

Global Infection Surveillance Solutions Market – By Infection

Based on infection, global infection surveillance solutions market is divided into Surgical Site Infections (SSI), Blood Stream Infections (BSI), and Urinary Tract Infections (UTI). The surgical site infections segment is expected to dominate the market during the period in analysis due to growing incidence of surgical site infection. The urinary tract infection (UTI) segment held the second highest market share in 2022 and is likely to continue to maintain its position. According to statistics given by womenshealth.gov, women are 30% more prone to UTI than men. Furthermore, the CDC reports that 75% of UTIs acquired in hospitals are the result of extended usage of urinary catheters. Furthermore, the European Institute for Disease Prevention and Control reports that 3% of all patients treated in ICU for more than two days had UTIs.

Infection Surveillance Solutions Market Size

Global Infection Surveillance Solutions Market – By End Use

Based on end use, global infection surveillance solutions market is divided into Long Term Care Facilities, Hospitals, and other segments (Clinics and Ambulatory Surgical Centers). The hospital segment held the highest market share and is expected to make substantial improvement throughout the forecast period. The increased burden of infectious and chronic health diseases has led in an increase in the number of people requiring frequent hospitalizations, resulting in a significant increase in hospital-acquired infections and associated healthcare expense. This has increased demand for improved healthcare infrastructure, leading in the development of new hospitals and healthcare facilities, which has improved the industry's outlook.

Global Infection Surveillance Solutions Market – By Region

Global infection surveillance solutions market covers five major regions: North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. North America held the highest market share. The region's massive market is mostly attributable to rising R&D activity in the medical sciences. Health and Human Services (HHS), which is overseen by the cabinet-level agency of the US federal government, is particularly liberal in sponsoring and maintaining technology research in medical sciences. According to studies, one out of every 25 hospitalized patients in the United States suffers from HAI. Hospitals are struggling to reduce infection rates because many of these infections originate in the intensive care unit (ICU). Furthermore, rising healthcare costs in the US are prompting individual hospitals to relocate or integrate with independent healthcare groups to form larger healthcare systems that can widen their service reach, leverage economies of scale, and withstand increasing regulatory pressures from the current government. These dynamics are driving the advancement of technology innovations in the hospital, which in turn boosts the market for infection surveillance systems.

Competitive Landscape

Major players operating in global infection surveillance solutions market include Cerner Corporation, Epic Systems Corporation, VigiLanz Corporation, Becton, Dickinson and Company, Premier Inc., DEB Group Ltd, RL Solutions, Baxter International Inc. (ICNet International), Gojo Industries Inc., and IBM Corporation (Truven Health Analytics). To further enhance their market share, these companies employ various strategies, including mergers and acquisitions, partnerships, joint ventures, license agreements, and new product launches.

Recent Developments

  • In June 2019- GOJO Industries, Inc. unveiled a new solution that uses Bluetooth Low Energy (BLE) technology to capture healthcare worker-specific hand hygiene events in real time.

Scope of the Report

Attributes

Details

Years Considered

Historical Data – 2019–2022

Base Year – 2022

Estimated Year – 2023

Forecast Period – 2023–2029

Facts Covered

Revenue in USD Million

Market Coverage

North America, Europe, Asia Pacific, Latin America, Middle East and Africa

Product/ Service Segmentation

Offering, Infection Type, End Use, Region

Key Players

Cerner Corporation, Epic Systems Corporation, VigiLanz Corporation, Becton, Dickinson and Company, Premier Inc., DEB Group Ltd, RL Solutions, Baxter International Inc. (ICNet International), Gojo Industries Inc., IBM Corporation (Truven Health Analytics)

 

By Offering

  • Software

  • Services

By Infection Type

  • Surgical Site Infections (SSI)

  • Blood Stream Infections (BSI)

  • Urinary Tract Infections (UTI)

By End Use

  • Long Term Care Facilities

  • Hospitals

By Region

  • North America

  • Europe

  • Asia Pacific

  • Latin America

  • Middle East and Africa

  1. Research Framework
    1. Research Objective
    2. Product Overview
    3. Market Segmentation
  2. Executive Summary
  3. Global Infection Surveillance Solutions Market Insights
    1. Industry Value Chain Analysis
    2. DROC Analysis
      1. Growth Drivers
        1. Growing Adoption of Antimicrobial Stewardship Programs
        2. Increasing Automotive and Transportation Industry
      2. Restraints
        1. High Cost of Deployment for Small Healthcare Organizations
        2. Privacy and Security Concerns
      3. Opportunities
        1. Growing incidences of Healthcare-Associated Infections (HAIs) Driving Demand for Infection Surveillance Solutions
      4. Challenges
        1. Limited Awareness and Education
    3. Technology Advancements/Recent Developments
    4. Regulatory Framework
    5. Porter’s Five Forces Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of New Entrants
      4. Threat of Substitutes
      5. Intensity of Rivalry
  4. Global Infection Surveillance Solutions Market Overview
    1. Market Size & Forecast, 2019–2029
      1. By Value (USD Million)
    2. Market Share & Forecast
      1. By Offering
        1. Software
          1. On-premises
          2. Web-based
        2. Services
          1. Maintenance and Support
          2. Consultation and Training
          3. Implementation Service
      2. By Infection Type
        1. Surgical Site Infections (SSI)
        2. Blood Stream Infections (BSI)
        3. Urinary Tract Infections (UTI)
        4. Others
      3. By End Use
        1. Long Term Care Facilities
        2. Hospitals
        3. Others (Clinics, Ambulatory Surgical Centers)
      4. By Region
        1. North America
        2. Europe
        3. Asia Pacific (APAC)
        4. Latin America (LATAM)
        5. Middle East and Africa (MEA)
  5. North America Infection Surveillance Solutions Market
    1. Market Size & Forecast, 2019–2029
      1. By Value (USD Million)
    2. Market Share & Forecast
      1. By Offering
      2. By Infection Type
      3. By End Use
      4. By Country
        1. US
          1. By Offering
          2. By Infection Type
          3. By End Use
        2. Canada
          1. By Offering
          2. By Infection Type
          3. By End Use
  6. Europe Infection Surveillance Solutions Market
    1. Market Size & Forecast, 2019–2029
      1. By Value (USD Million)
    2. Market Share & Forecast
      1. By Offering
      2. By Infection Type
      3. By End Use
      4. By Country
        1. Germany
          1. By Offering
          2. By Infection Type
          3. By End Use
        2. UK
          1. By Offering
          2. By Infection Type
          3. By End Use
        3. Italy
          1. By Offering
          2. By Infection Type
          3. By End Use
        4. France
          1. By Offering
          2. By Infection Type
          3. By End Use
        5. Spain
          1. By Offering
          2. By Infection Type
          3. By End Use
        6. The Netherlands
          1. By Offering
          2. By Infection Type
          3. By End Use
        7. Rest of Europe
          1. By Offering
          2. By Infection Type
          3. By End Use
  7. Asia-Pacific Infection Surveillance Solutions Market
    1. Market Size & Forecast, 2019–2029
      1. By Value (USD Million)
    2. Market Share & Forecast
      1. By Offering
      2. By Infection Type
      3. By End Use
      4. By Country
        1. China
          1. By Offering
          2. By Infection Type
          3. By End Use
        2. India
          1. By Offering
          2. By Infection Type
          3. By End Use
        3. Japan
          1. By Offering
          2. By Infection Type
          3. By End Use
        4. South Korea
          1. By Offering
          2. By Infection Type
          3. By End Use
        5. Australia & New Zealand
          1. By Offering
          2. By Infection Type
          3. By End Use
        6. Indonesia
          1. By Offering
          2. By Infection Type
          3. By End Use
        7. Malaysia
          1. By Offering
          2. By Infection Type
          3. By End Use
        8. Singapore
          1. By Offering
          2. By Infection Type
          3. By End Use
        9. Philippines
          1. By Offering
          2. By Infection Type
          3. By End Use
        10. Vietnam
          1. By Offering
          2. By Infection Type
          3. By End Use
        11. Rest of APAC
          1. By Offering
          2. By Infection Type
          3. By End Use
  8. Latin America Infection Surveillance Solutions Market
    1. Market Size & Forecast, 2019–2029
      1. By Value (USD Million)
    2. Market Share & Forecast
      1. By Offering
      2. By Infection Type
      3. By End Use
      4. By Country
        1. Brazil
          1. By Offering
          2. By Infection Type
          3. By End Use
        2. Mexico
          1. By Offering
          2. By Infection Type
          3. By End Use
        3. Argentina
          1. By Offering
          2. By Infection Type
          3. By End Use
        4. Peru
          1. By Offering
          2. By Infection Type
          3. By End Use
        5. Rest of LATAM
          1. By Offering
          2. By Infection Type
          3. By End Use
  9. Middle East & Africa Infection Surveillance Solutions Market
    1. Market Size & Forecast, 2019–2029
      1. By Value (USD Million)
    2. Market Share & Forecast
      1. By Offering
      2. By Infection Type
      3. By End Use
      4. By Country
        1. Saudi Arabia
          1. By Offering
          2. By Infection Type
          3. By End Use
        2. UAE
          1. By Offering
          2. By Infection Type
          3. By End Use
        3. Qatar
          1. By Offering
          2. By Infection Type
          3. By End Use
        4. Kuwait
          1. By Offering
          2. By Infection Type
          3. By End Use
        5. South Africa
          1. By Offering
          2. By Infection Type
          3. By End Use
        6. Nigeria
          1. By Offering
          2. By Infection Type
          3. By End Use
        7. Algeria
          1. By Offering
          2. By Infection Type
          3. By End Use
        8. Rest of MEA
          1. By Offering
          2. By Infection Type
          3. By End Use
  10. Competitive Landscape
    1. List of Key Players and Their Offerings
    2. Global Infection Surveillance Solutions Company Market Share Analysis, 2022
    3. Competitive Benchmarking, By Operating Parameters
    4. Key Strategic Developments (Mergers, Acquisitions, Partnerships, etc.)
  11. Impact of Covid-19 on Global Infection Surveillance Solutions Market
  12. Company Profile (Company Overview, Financial Matrix, Competitive Landscape, Key Personnel, Key Competitors, Contact Address, Strategic Outlook, SWOT Analysis)
    1. Cerner Corporation
    2. Epic Systems Corporation
    3. VigiLanz Corporation
    4. Becton, Dickinson and Company
    5. Premier Inc.
    6. DEB Group Ltd
    7. RL Solutions
    8. Baxter International Inc. (ICNet International)
    9. Gojo Industries Inc.
    10.  IBM Corporation (Truven Health Analytics)
    11. Other Prominent Players
  13. Key Strategic Recommendations
  14. Research Methodology
    1.  Qualitative Research
      1.  Primary & Secondary Research
    2.  Quantitative Research
    3.  Market Breakdown & Data Triangulation
      1.  Secondary Research
      2.  Primary Research
    4.  Breakdown of Primary Research Respondents, By Region
    5.  Assumptions & Limitations

*Financial information of case of non-listed companies can be provided as per availability.

**The segmentation and the companies are subject to modifications based on in-depth secondary research for the final deliverable

 

 

List of Figures

 

Figure 1       Global Infection Surveillance Solutions Segmentation

Figure 2       Global Infection Surveillance Solutions Market Value Chain Analysis

Figure 3       Company Market Share Analysis, 2022

Figure 4       Global Infection Surveillance Solutions Market Size, By Value (USD Million), 2019–2029

Figure 5       Global Infection Surveillance Solutions Market Share, By Offering, By Value, 2019–2029

Figure 6       Global Infection Surveillance Solutions Market Share, By Infection Type, By Value, 2019–2029

Figure 7       Global Infection Surveillance Solutions Market Share, By End Use, By Value, 2019–2029

Figure 8       Global Infection Surveillance Solutions Market Share, By Region, By Value, 2019–2029

Figure 9       North America Infection Surveillance Solutions Market Size, By Value (USD Million), 2019–2029

Figure 10     North America Infection Surveillance Solutions Market Share, By Offering, By Value, 2019–2029

Figure 11     North America Infection Surveillance Solutions Market Share, By Infection Type, By Value, 2019–2029

Figure 12     North America Infection Surveillance Solutions Market Share, By End Use, By Value, 2019–2029

Figure 13     North America Infection Surveillance Solutions Market Share, By Country, By Value, 2019–2029

Figure 14     US Infection Surveillance Solutions Market Size, By Value (USD Million), 2019–2029

Figure 15     US Infection Surveillance Solutions Market Share, By Offering, By Value, 2019–2029

Figure 16     US Infection Surveillance Solutions Market Share, By Infection Type, By Value, 2019–2029

Figure 17     US Infection Surveillance Solutions Market Share, By End Use, By Value, 2019–2029

Figure 18     Canada Infection Surveillance Solutions Market Size, By Value (USD Million), 2019–2029

Figure 19     Canada Infection Surveillance Solutions Market Share, By Offering, By Value, 2019–2029

Figure 20     Canada Infection Surveillance Solutions Market Share, By Infection Type, By Value, 2019–2029

Figure 21     Canada Infection Surveillance Solutions Market Share, By End Use, By Value, 2019–2029

Figure 22     Europe Infection Surveillance Solutions Market Size, By Value (USD Million), 2019–2029

Figure 23     Europe Infection Surveillance Solutions Market Share, By Offering, By Value, 2019–2029

Figure 24     Europe Infection Surveillance Solutions Market Share, By Infection Type, By Value, 2019–2029

Figure 25     Europe Infection Surveillance Solutions Market Share, By End Use, By Value, 2019–2029

Figure 26     Europe Infection Surveillance Solutions Market Share, By Country, By Value, 2019–2029

Figure 27     Germany Infection Surveillance Solutions Market Size, By Value (USD Million), 2019–2029

Figure 28     Germany Infection Surveillance Solutions Market Share, By Offering, By Value, 2019–2029

Figure 29     Germany Infection Surveillance Solutions Market Share, By Infection Type, By Value, 2019–2029

Figure 30     Germany Infection Surveillance Solutions Market Share, By End Use, By Value, 2019–2029

Figure 31     UK Infection Surveillance Solutions Market Size, By Value (USD Million), 2019–2029

Figure 32     UK Infection Surveillance Solutions Market Share, By Offering, By Value, 2019–2029

Figure 33     UK Infection Surveillance Solutions Market Share, By Infection Type, By Value, 2019–2029

Figure 34     UK Infection Surveillance Solutions Market Share, By End Use, By Value, 2019–2029

Figure 35     Italy Infection Surveillance Solutions Market Size, By Value (USD Million), 2019–2029

Figure 36     Italy Infection Surveillance Solutions Market Share, By Offering, By Value, 2019–2029

Figure 37     Italy Infection Surveillance Solutions Market Share, By Infection Type, By Value, 2019–2029

Figure 38     Italy Infection Surveillance Solutions Market Share, By End Use, By Value, 2019–2029

Figure 39     France Infection Surveillance Solutions Market Size, By Value (USD Million), 2019–2029

Figure 40     France Infection Surveillance Solutions Market Share, By Offering, By Value, 2019–2029

Figure 41     France Infection Surveillance Solutions Market Share, By Infection Type, By Value, 2019–2029

Figure 42     France Infection Surveillance Solutions Market Share, By End Use, By Value, 2019–2029

Figure 43     Spain Infection Surveillance Solutions Market Size, By Value (USD Million), 2019–2029

Figure 44     Spain Infection Surveillance Solutions Market Share, By Offering, By Value, 2019–2029

Figure 45     Spain Infection Surveillance Solutions Market Share, By Infection Type, By Value, 2019–2029

Figure 46     Spain Infection Surveillance Solutions Market Share, By End Use, By Value, 2019–2029

Figure 47     The Netherlands Infection Surveillance Solutions Market Size, By Value (USD Million), 2019–2029

Figure 48     The Netherlands Infection Surveillance Solutions Market Share, By Offering, By Value, 2019–2029

Figure 49     The Netherlands Infection Surveillance Solutions Market Share, By Infection Type, By Value, 2019–2029

Figure 50     The Netherlands Infection Surveillance Solutions Market Share, By End Use, By Value, 2019–2029

Figure 51     Rest of Europe Infection Surveillance Solutions Market Size, By Value (USD Million), 2019–2029

Figure 52     Rest of Europe Infection Surveillance Solutions Market Share, By Offering, By Value, 2019–2029

Figure 53     Rest of Europe Infection Surveillance Solutions Market Share, By Infection Type, By Value, 2019–2029

Figure 54     Rest of Europe Infection Surveillance Solutions Market Share, By End Use, By Value, 2019–2029

Figure 55     Asia-Pacific Infection Surveillance Solutions Market Size, By Value (USD Million), 2019–2029

Figure 56     Asia-Pacific Infection Surveillance Solutions Market Share, By Offering, By Value, 2019–2029

Figure 57     Asia-Pacific Infection Surveillance Solutions Market Share, By Infection Type, By Value, 2019–2029

Figure 58     Asia-Pacific Infection Surveillance Solutions Market Share, By End Use, By Value, 2019–2029

Figure 59     Asia-Pacific Infection Surveillance Solutions Market Share, By Country, By Value, 2019–2029

Figure 60     China Infection Surveillance Solutions Market Size, By Value (USD Million), 2019–2029

Figure 61     China Infection Surveillance Solutions Market Share, By Offering, By Value, 2019–2029

Figure 62     China Infection Surveillance Solutions Market Share, By Infection Type, By Value, 2019–2029

Figure 63     China Infection Surveillance Solutions Market Share, By End Use, By Value, 2019–2029

Figure 64     India Infection Surveillance Solutions Market Size, By Value (USD Million), 2019–2029

Figure 65     India Infection Surveillance Solutions Market Share, By Offering, By Value, 2019–2029

Figure 66     India Infection Surveillance Solutions Market Share, By Infection Type, By Value, 2019–2029

Figure 67     India Infection Surveillance Solutions Market Share, By End Use, By Value, 2019–2029

Figure 68     Japan Infection Surveillance Solutions Market Size, By Value (USD Million), 2019–2029

Figure 69     Japan Infection Surveillance Solutions Market Share, By Offering, By Value, 2019–2029

Figure 70     Japan Infection Surveillance Solutions Market Share, By Infection Type, By Value, 2019–2029

Figure 71     Japan Infection Surveillance Solutions Market Share, By End Use, By Value, 2019–2029

Figure 72     South Korea Infection Surveillance Solutions Market Size, By Value (USD Million), 2019–2029

Figure 73     South Korea Infection Surveillance Solutions Market Share, By Offering, By Value, 2019–2029

Figure 74     South Korea Infection Surveillance Solutions Market Share, By Infection Type, By Value, 2019–2029

Figure 75     South Korea Infection Surveillance Solutions Market Share, By End Use, By Value, 2019–2029

Figure 76     Australia & New Zealand Infection Surveillance Solutions Market Size, By Value (USD Million), 2019–2029

Figure 77     Australia & New Zealand Infection Surveillance Solutions Market Share, By Offering, By Value, 2019–2029

Figure 78     Australia & New Zealand Infection Surveillance Solutions Market Share, By Infection Type, By Value, 2019–2029

Figure 79     Australia & New Zealand Infection Surveillance Solutions Market Share, By End Use, By Value, 2019–2029

Figure 80     Indonesia Infection Surveillance Solutions Market Size, By Value (USD Million), 2019–2029

Figure 81     Indonesia Infection Surveillance Solutions Market Share, By Offering, By Value, 2019–2029

Figure 82     Indonesia Infection Surveillance Solutions Market Share, By Infection Type, By Value, 2019–2029

Figure 83     Indonesia Infection Surveillance Solutions Market Share, By End Use, By Value, 2019–2029

Figure 84     Malaysia Infection Surveillance Solutions Market Size, By Value (USD Million), 2019–2029

Figure 85     Malaysia Infection Surveillance Solutions Market Share, By Offering, By Value, 2019–2029

Figure 86     Malaysia Infection Surveillance Solutions Market Share, By Infection Type, By Value, 2019–2029

Figure 87     Malaysia Infection Surveillance Solutions Market Share, By End Use, By Value, 2019–2029

Figure 88     Singapore Infection Surveillance Solutions Market Size, By Value (USD Million), 2019–2029

Figure 89     Singapore Infection Surveillance Solutions Market Share, By Offering, By Value, 2019–2029

Figure 90     Singapore Infection Surveillance Solutions Market Share, By Infection Type, By Value, 2019–2029

Figure 91     Singapore Infection Surveillance Solutions Market Share, By End Use, By Value, 2019–2029

Figure 92     Philippines Infection Surveillance Solutions Market Size, By Value (USD Million), 2019–2029

Figure 93     Philippines Infection Surveillance Solutions Market Share, By Offering, By Value, 2019–2029

Figure 94     Philippines Infection Surveillance Solutions Market Share, By Infection Type, By Value, 2019–2029

Figure 95     Philippines Infection Surveillance Solutions Market Share, By End Use, By Value, 2019–2029

Figure 96     Vietnam Infection Surveillance Solutions Market Size, By Value (USD Million), 2019–2029

Figure 97     Vietnam Infection Surveillance Solutions Market Share, By Offering, By Value, 2019–2029

Figure 98     Vietnam Infection Surveillance Solutions Market Share, By Infection Type, By Value, 2019–2029

Figure 99     Vietnam Infection Surveillance Solutions Market Share, By End Use, By Value, 2019–2029

Figure 100   Rest of APAC Infection Surveillance Solutions Market Size, By Value (USD Million), 2019–2029

Figure 101   Rest of APAC Infection Surveillance Solutions Market Share, By Offering, By Value, 2019–2029

Figure 102   Rest of APAC Infection Surveillance Solutions Market Share, By Infection Type, By Value, 2019–2029

Figure 103   Rest of APAC Infection Surveillance Solutions Market Share, By End Use, By Value, 2019–2029

Figure 104   Latin America Infection Surveillance Solutions Market Size, By Value (USD Million), 2019–2029

Figure 105   Latin America Infection Surveillance Solutions Market Share, By Offering, By Value, 2019–2029

Figure 106   Latin America Infection Surveillance Solutions Market Share, By Infection Type, By Value, 2019–2029

Figure 107   Latin America Infection Surveillance Solutions Market Share, By End Use, By Value, 2019–2029

Figure 108   Latin America Infection Surveillance Solutions Market Share, By Country, By Value, 2019–2029

Figure 109   Brazil Infection Surveillance Solutions Market Size, By Value (USD Million), 2019–2029

Figure 110   Brazil Infection Surveillance Solutions Market Share, By Offering, By Value, 2019–2029

Figure 111   Brazil Infection Surveillance Solutions Market Share, By Infection Type, By Value, 2019–2029

Figure 112   Brazil Infection Surveillance Solutions Market Share, By End Use, By Value, 2019–2029

Figure 113   Mexico Infection Surveillance Solutions Market Size, By Value (USD Million), 2019–2029

Figure 114   Mexico Infection Surveillance Solutions Market Share, By Offering, By Value, 2019–2029

Figure 115   Mexico Infection Surveillance Solutions Market Share, By Infection Type, By Value, 2019–2029

Figure 116   Mexico Infection Surveillance Solutions Market Share, By End Use, By Value, 2019–2029

Figure 117   Argentina Infection Surveillance Solutions Market Size, By Value (USD Million), 2019–2029

Figure 118   Argentina Infection Surveillance Solutions Market Share, By Offering, By Value, 2019–2029

Figure 119   Argentina Infection Surveillance Solutions Market Share, By Infection Type, By Value, 2019–2029

Figure 120   Argentina Infection Surveillance Solutions Market Share, By End Use, By Value, 2019–2029

Figure 121   Peru Infection Surveillance Solutions Market Size, By Value (USD Million), 2019–2029

Figure 122   Peru Infection Surveillance Solutions Market Share, By Offering, By Value, 2019–2029

Figure 123   Peru Infection Surveillance Solutions Market Share, By Infection Type, By Value, 2019–2029

Figure 124   Peru Infection Surveillance Solutions Market Share, By End Use, By Value, 2019–2029

Figure 125   Rest of LATAM Infection Surveillance Solutions Market Size, By Value (USD Million), 2019–2029

Figure 126   Rest of LATAM Infection Surveillance Solutions Market Share, By Offering, By Value, 2019–2029

Figure 127   Rest of LATAM Infection Surveillance Solutions Market Share, By Infection Type, By Value, 2019–2029

Figure 128   Rest of LATAM Infection Surveillance Solutions Market Share, By End Use, By Value, 2019–2029

Figure 129   Middle East & Africa Infection Surveillance Solutions Market Size, By Value (USD Million), 2019–2029

Figure 130   Middle East & Africa Infection Surveillance Solutions Market Share, By Offering, By Value, 2019–2029

Figure 131   Middle East & Africa Infection Surveillance Solutions Market Share, By Infection Type, By Value, 2019–2029

Figure 132   Middle East & Africa Infection Surveillance Solutions Market Share, By End Use, By Value, 2019–2029

Figure 133   Middle East & Africa Infection Surveillance Solutions Market Share, By Country, By Value, 2019–2029

Figure 134   Saudi Arabia Infection Surveillance Solutions Market Size, By Value (USD Million), 2019–2029

Figure 135   Saudi Arabia Infection Surveillance Solutions Market Share, By Offering, By Value, 2019–2029

Figure 136   Saudi Arabia Infection Surveillance Solutions Market Share, By Infection Type, By Value, 2019–2029

Figure 137   Saudi Arabia Infection Surveillance Solutions Market Share, By End Use, By Value, 2019–2029

Figure 138   UAE Infection Surveillance Solutions Market Size, By Value (USD Million), 2019–2029

Figure 139   UAE Infection Surveillance Solutions Market Share, By Offering, By Value, 2019–2029

Figure 140   UAE Infection Surveillance Solutions Market Share, By Infection Type, By Value, 2019–2029

Figure 141   UAE Infection Surveillance Solutions Market Share, By End Use, By Value, 2019–2029

Figure 142   Qatar Infection Surveillance Solutions Market Size, By Value (USD Million), 2019–2029

Figure 143   Qatar Infection Surveillance Solutions Market Share, By Offering, By Value, 2019–2029

Figure 144   Qatar Infection Surveillance Solutions Market Share, By Infection Type, By Value, 2019–2029

Figure 145   Qatar Infection Surveillance Solutions Market Share, By End Use, By Value, 2019–2029

Figure 146   Kuwait Infection Surveillance Solutions Market Size, By Value (USD Million), 2019–2029

Figure 147   Kuwait Infection Surveillance Solutions Market Share, By Offering, By Value, 2019–2029

Figure 148   Kuwait Infection Surveillance Solutions Market Share, By Infection Type, By Value, 2019–2029

Figure 149   Kuwait Infection Surveillance Solutions Market Share, By End Use, By Value, 2019–2029

Figure 150   South Africa Infection Surveillance Solutions Market Size, By Value (USD Million), 2019–2029

Figure 151   South Africa Infection Surveillance Solutions Market Share, By Offering, By Value, 2019–2029

Figure 152   South Africa Infection Surveillance Solutions Market Share, By Infection Type, By Value, 2019–2029

Figure 153   South Africa Infection Surveillance Solutions Market Share, By End Use, By Value, 2019–2029

Figure 154   Nigeria Infection Surveillance Solutions Market Size, By Value (USD Million), 2019–2029

Figure 155   Nigeria Infection Surveillance Solutions Market Share, By Offering, By Value, 2019–2029

Figure 156   Nigeria Infection Surveillance Solutions Market Share, By Infection Type, By Value, 2019–2029

Figure 157   Nigeria Infection Surveillance Solutions Market Share, By End Use, By Value, 2019–2029

Figure 158   Algeria Infection Surveillance Solutions Market Size, By Value (USD Million), 2019–2029

Figure 159   Algeria Infection Surveillance Solutions Market Share, By Offering, By Value, 2019–2029

Figure 160   Algeria Infection Surveillance Solutions Market Share, By Infection Type, By Value, 2019–2029

Figure 161   Algeria Infection Surveillance Solutions Market Share, By End Use, By Value, 2019–2029

Figure 162   Rest of MEA Infection Surveillance Solutions Market Size, By Value (USD Million), 2019–2029

Figure 163   Rest of MEA Infection Surveillance Solutions Market Share, By Offering, By Value, 2019–2029

Figure 164   Rest of MEA Infection Surveillance Solutions Market Share, By Infection Type, By Value, 2019–2029

Figure 165   Rest of MEA Infection Surveillance Solutions Market Share, By End Use, By Value, 2019–2029

 

List of Tables

 

Table 1        Global Infection Surveillance Solutions Market Size, By Value (USD Million), 2019–2029

Table 2        Global Infection Surveillance Solutions Market Size, By Offering, By Value, 2019–2029

Table 3        Global Infection Surveillance Solutions Market Size, By Infection Type, By Value, 2019–2029

Table 4        Global Infection Surveillance Solutions Market Size, By End Use, By Value, 2019–2029

Table 5        Global Infection Surveillance Solutions Market Size, By Region, By Value, 2019–2029

Table 6        North America Infection Surveillance Solutions Market Size, By Value (USD Million), 2019–2029

Table 7        North America Infection Surveillance Solutions Market Size, By Offering, By Value, 2019–2029

Table 8        North America Infection Surveillance Solutions Market Size, By Infection Type, By Value, 2019–2029

Table 9        North America Infection Surveillance Solutions Market Size, By End Use, By Value, 2019–2029

Table 10      North America Infection Surveillance Solutions Market Size, By Country, By Value, 2019–2029

Table 11      US Infection Surveillance Solutions Market Size, By Value (USD Million), 2019–2029

Table 12      US Infection Surveillance Solutions Market Size, By Offering, By Value, 2019–2029

Table 13      US Infection Surveillance Solutions Market Size, By Infection Type, By Value, 2019–2029

Table 14      US Infection Surveillance Solutions Market Size, By End Use, By Value, 2019–2029

Table 15      Canada Infection Surveillance Solutions Market Size, By Value (USD Million), 2019–2029

Table 16      Canada Infection Surveillance Solutions Market Size, By Offering, By Value, 2019–2029

Table 17      Canada Infection Surveillance Solutions Market Size, By Infection Type, By Value, 2019–2029

Table 18      Canada Infection Surveillance Solutions Market Size, By End Use, By Value, 2019–2029

Table 19      Europe Infection Surveillance Solutions Market Size, By Value (USD Million), 2019–2029

Table 20      Europe Infection Surveillance Solutions Market Size, By Offering, By Value, 2019–2029

Table 21      Europe Infection Surveillance Solutions Market Size, By Infection Type, By Value, 2019–2029

Table 22      Europe Infection Surveillance Solutions Market Size, By End Use, By Value, 2019–2029

Table 23      Europe Infection Surveillance Solutions Market Size, By Country, By Value, 2019–2029

Table 24      Germany Infection Surveillance Solutions Market Size, By Value (USD Million), 2019–2029

Table 25      Germany Infection Surveillance Solutions Market Size, By Offering, By Value, 2019–2029

Table 26      Germany Infection Surveillance Solutions Market Size, By Infection Type, By Value, 2019–2029

Table 27      Germany Infection Surveillance Solutions Market Size, By End Use, By Value, 2019–2029

Table 28      UK Infection Surveillance Solutions Market Size, By Value (USD Million), 2019–2029

Table 29      UK Infection Surveillance Solutions Market Size, By Offering, By Value, 2019–2029

Table 30      UK Infection Surveillance Solutions Market Size, By Infection Type, By Value, 2019–2029

Table 31      UK Infection Surveillance Solutions Market Size, By End Use, By Value, 2019–2029

Table 32      Italy Infection Surveillance Solutions Market Size, By Value (USD Million), 2019–2029

Table 33      Italy Infection Surveillance Solutions Market Size, By Offering, By Value, 2019–2029

Table 34      Italy Infection Surveillance Solutions Market Size, By Infection Type, By Value, 2019–2029

Table 35      Italy Infection Surveillance Solutions Market Size, By End Use, By Value, 2019–2029

Table 36      France Infection Surveillance Solutions Market Size, By Value (USD Million), 2019–2029

Table 37      France Infection Surveillance Solutions Market Size, By Offering, By Value, 2019–2029

Table 38      France Infection Surveillance Solutions Market Size, By Infection Type, By Value, 2019–2029

Table 39      France Infection Surveillance Solutions Market Size, By End Use, By Value, 2019–2029

Table 40      Spain Infection Surveillance Solutions Market Size, By Value (USD Million), 2019–2029

Table 41      Spain Infection Surveillance Solutions Market Size, By Offering, By Value, 2019–2029

Table 42      Spain Infection Surveillance Solutions Market Size, By Infection Type, By Value, 2019–2029

Table 43      Spain Infection Surveillance Solutions Market Size, By End Use, By Value, 2019–2029

Table 44      The Netherlands Infection Surveillance Solutions Market Size, By Value (USD Million), 2019–2029

Table 45      The Netherlands Infection Surveillance Solutions Market Size, By Offering, By Value, 2019–2029

Table 46      The Netherlands Infection Surveillance Solutions Market Size, By Infection Type, By Value, 2019–2029

Table 47      The Netherlands Infection Surveillance Solutions Market Size, By End Use, By Value, 2019–2029

Table 48      Rest of Europe Infection Surveillance Solutions Market Size, By Value (USD Million), 2019–2029

Table 49      Rest of Europe Infection Surveillance Solutions Market Size, By Offering, By Value, 2019–2029

Table 50      Rest of Europe Infection Surveillance Solutions Market Size, By Infection Type, By Value, 2019–2029

Table 51      Rest of Europe Infection Surveillance Solutions Market Size, By End Use, By Value, 2019–2029

Table 52      Asia-Pacific Infection Surveillance Solutions Market Size, By Value (USD Million), 2019–2029

Table 53      Asia-Pacific Infection Surveillance Solutions Market Size, By Offering, By Value, 2019–2029

Table 54      Asia-Pacific Infection Surveillance Solutions Market Size, By Infection Type, By Value, 2019–2029

Table 55      Asia-Pacific Infection Surveillance Solutions Market Size, By End Use, By Value, 2019–2029

Table 56      Asia-Pacific Infection Surveillance Solutions Market Size, By Country, By Value, 2019–2029

 

Table 57      China Infection Surveillance Solutions Market Size, By Value (USD Million), 2019–2029

Table 58      China Infection Surveillance Solutions Market Size, By Offering, By Value, 2019–2029

Table 59      China Infection Surveillance Solutions Market Size, By Infection Type, By Value, 2019–2029

Table 60      China Infection Surveillance Solutions Market Size, By End Use, By Value, 2019–2029

Table 61      India Infection Surveillance Solutions Market Size, By Value (USD Million), 2019–2029

Table 62      India Infection Surveillance Solutions Market Size, By Offering, By Value, 2019–2029

Table 63      India Infection Surveillance Solutions Market Size, By Infection Type, By Value, 2019–2029

Table 64      India Infection Surveillance Solutions Market Size, By End Use, By Value, 2019–2029

Table 65      Japan Infection Surveillance Solutions Market Size, By Value (USD Million), 2019–2029

Table 66      Japan Infection Surveillance Solutions Market Size, By Offering, By Value, 2019–2029

Table 67      Japan Infection Surveillance Solutions Market Size, By Infection Type, By Value, 2019–2029

Table 68      Japan Infection Surveillance Solutions Market Size, By End Use, By Value, 2019–2029

Table 69      South Korea Infection Surveillance Solutions Market Size, By Value (USD Million), 2019–2029

Table 70      South Korea Infection Surveillance Solutions Market Size, By Offering, By Value, 2019–2029

Table 71      South Korea Infection Surveillance Solutions Market Size, By Infection Type, By Value, 2019–2029

Table 72      South Korea Infection Surveillance Solutions Market Size, By End Use, By Value, 2019–2029

Table 73      Australia & New Zealand Infection Surveillance Solutions Market Size, By Value (USD Million), 2019–2029

Table 74      Australia & New Zealand Infection Surveillance Solutions Market Size, By Offering, By Value, 2019–2029

Table 75      Australia & New Zealand Infection Surveillance Solutions Market Size, By Infection Type, By Value, 2019–2029

Table 76      Australia & New Zealand Infection Surveillance Solutions Market Size, By End Use, By Value, 2019–2029

Table 77      Indonesia Infection Surveillance Solutions Market Size, By Value (USD Million), 2019–2029

Table 78      Indonesia Infection Surveillance Solutions Market Size, By Offering, By Value, 2019–2029

Table 79      Indonesia Infection Surveillance Solutions Market Size, By Infection Type, By Value, 2019–2029

Table 80      Indonesia Infection Surveillance Solutions Market Size, By End Use, By Value, 2019–2029

Table 81      Malaysia Infection Surveillance Solutions Market Size, By Value (USD Million), 2019–2029

Table 82      Malaysia Infection Surveillance Solutions Market Size, By Offering, By Value, 2019–2029

Table 83      Malaysia Infection Surveillance Solutions Market Size, By Infection Type, By Value, 2019–2029

Table 84      Malaysia Infection Surveillance Solutions Market Size, By End Use, By Value, 2019–2029

Table 85      Singapore Infection Surveillance Solutions Market Size, By Value (USD Million), 2019–2029

Table 86      Singapore Infection Surveillance Solutions Market Size, By Offering, By Value, 2019–2029

Table 87      Singapore Infection Surveillance Solutions Market Size, By Infection Type, By Value, 2019–2029

Table 88      Singapore Infection Surveillance Solutions Market Size, By End Use, By Value, 2019–2029

Table 89      Philippines Infection Surveillance Solutions Market Size, By Value (USD Million), 2019–2029

Table 90      Philippines Infection Surveillance Solutions Market Size, By Offering, By Value, 2019–2029

Table 91      Philippines Infection Surveillance Solutions Market Size, By Infection Type, By Value, 2019–2029

Table 92      Philippines Infection Surveillance Solutions Market Size, By End Use, By Value, 2019–2029

Table 93      Vietnam Infection Surveillance Solutions Market Size, By Value (USD Million), 2019–2029

Table 94      Vietnam Infection Surveillance Solutions Market Size, By Offering, By Value, 2019–2029

Table 95      Vietnam Infection Surveillance Solutions Market Size, By Infection Type, By Value, 2019–2029

Table 96      Vietnam Infection Surveillance Solutions Market Size, By End Use, By Value, 2019–2029

Table 97      Rest of APAC Infection Surveillance Solutions Market Size, By Value (USD Million), 2019–2029

Table 98      Rest of APAC Infection Surveillance Solutions Market Size, By Offering, By Value, 2019–2029

Table 99      Rest of APAC Infection Surveillance Solutions Market Size, By Infection Type, By Value, 2019–2029

Table 100    Rest of APAC Infection Surveillance Solutions Market Size, By End Use, By Value, 2019–2029

Table 101    Latin America Infection Surveillance Solutions Market Size, By Value (USD Million), 2019–2029

Table 102    Latin America Infection Surveillance Solutions Market Size, By Offering, By Value, 2019–2029

Table 103    Latin America Infection Surveillance Solutions Market Size, By Infection Type, By Value, 2019–2029

Table 104    Latin America Infection Surveillance Solutions Market Size, By End Use, By Value, 2019–2029

Table 105    Latin America Infection Surveillance Solutions Market Size, By Country, By Value, 2019–2029

Table 106    Brazil Infection Surveillance Solutions Market Size, By Value (USD Million), 2019–2029

Table 107    Brazil Infection Surveillance Solutions Market Size, By Offering, By Value, 2019–2029

Table 108    Brazil Infection Surveillance Solutions Market Size, By Infection Type, By Value, 2019–2029

Table 109    Brazil Infection Surveillance Solutions Market Size, By End Use, By Value, 2019–2029

Table 110    Mexico Infection Surveillance Solutions Market Size, By Value (USD Million), 2019–2029

Table 111    Mexico Infection Surveillance Solutions Market Size, By Offering, By Value, 2019–2029

Table 112    Mexico Infection Surveillance Solutions Market Size, By Infection Type, By Value, 2019–2029

Table 113    Mexico Infection Surveillance Solutions Market Size, By End Use, By Value, 2019–2029

Table 114    Argentina Infection Surveillance Solutions Market Size, By Value (USD Million), 2019–2029

Table 115    Argentina Infection Surveillance Solutions Market Size, By Offering, By Value, 2019–2029

Table 116    Argentina Infection Surveillance Solutions Market Size, By Infection Type, By Value, 2019–2029

Table 117    Argentina Infection Surveillance Solutions Market Size, By End Use, By Value, 2019–2029

Table 118    Peru Infection Surveillance Solutions Market Size, By Value (USD Million), 2019–2029

Table 119    Peru Infection Surveillance Solutions Market Size, By Offering, By Value, 2019–2029

Table 120    Peru Infection Surveillance Solutions Market Size, By Infection Type, By Value, 2019–2029

Table 121    Peru Infection Surveillance Solutions Market Size, By End Use, By Value, 2019–2029

Table 122    Rest of LATAM Infection Surveillance Solutions Market Size, By Value (USD Million), 2019–2029

Table 123    Rest of LATAM Infection Surveillance Solutions Market Size, By Offering, By Value, 2019–2029

Table 124    Rest of LATAM Infection Surveillance Solutions Market Size, By Infection Type, By Value, 2019–2029

Table 125    Rest of LATAM Infection Surveillance Solutions Market Size, By End Use, By Value, 2019–2029

Table 126    Middle East & Africa Infection Surveillance Solutions Market Size, By Value (USD Million), 2019–2029

Table 127    Middle East & Africa Infection Surveillance Solutions Market Size, By Offering, By Value, 2019–2029

Table 128    Middle East & Africa Infection Surveillance Solutions Market Size, By Infection Type, By Value, 2019–2029

Table 129    Middle East & Africa Infection Surveillance Solutions Market Size, By End Use, By Value, 2019–2029

Table 130    Middle East & Africa Infection Surveillance Solutions Market Size, By Country, By Value, 2019–2029

Table 131    Saudi Arabia Infection Surveillance Solutions Market Size, By Value (USD Million), 2019–2029

Table 132    Saudi Arabia Infection Surveillance Solutions Market Size, By Offering, By Value, 2019–2029

Table 133    Saudi Arabia Infection Surveillance Solutions Market Size, By Infection Type, By Value, 2019–2029

Table 134    Saudi Arabia Infection Surveillance Solutions Market Size, By End Use, By Value, 2019–2029

Table 135    UAE Infection Surveillance Solutions Market Size, By Value (USD Million), 2019–2029

Table 136    UAE Infection Surveillance Solutions Market Size, By Offering, By Value, 2019–2029

Table 137    UAE Infection Surveillance Solutions Market Size, By Infection Type, By Value, 2019–2029

Table 138    UAE Infection Surveillance Solutions Market Size, By End Use, By Value, 2019–2029

Table 139    Qatar Infection Surveillance Solutions Market Size, By Value (USD Million), 2019–2029

Table 140    Qatar Infection Surveillance Solutions Market Size, By Offering, By Value, 2019–2029

Table 141    Qatar Infection Surveillance Solutions Market Size, By Infection Type, By Value, 2019–2029

Table 142    Qatar Infection Surveillance Solutions Market Size, By End Use, By Value, 2019–2029

Table 143    Kuwait Infection Surveillance Solutions Market Size, By Value (USD Million), 2019–2029

Table 144    Kuwait Infection Surveillance Solutions Market Size, By Offering, By Value, 2019–2029

Table 145    Kuwait Infection Surveillance Solutions Market Size, By Infection Type, By Value, 2019–2029

Table 146    Kuwait Infection Surveillance Solutions Market Size, By End Use, By Value, 2019–2029

Table 147    South Africa Infection Surveillance Solutions Market Size, By Value (USD Million), 2019–2029

Table 148    South Africa Infection Surveillance Solutions Market Size, By Offering, By Value, 2019–2029

Table 149    South Africa Infection Surveillance Solutions Market Size, By Infection Type, By Value, 2019–2029

Table 150    South Africa Infection Surveillance Solutions Market Size, By End Use, By Value, 2019–2029

Table 151    Nigeria Infection Surveillance Solutions Market Size, By Value (USD Million), 2019–2029

Table 152    Nigeria Infection Surveillance Solutions Market Size, By Offering, By Value, 2019–2029

Table 153    Nigeria Infection Surveillance Solutions Market Size, By Infection Type, By Value, 2019–2029

Table 154    Nigeria Infection Surveillance Solutions Market Size, By End Use, By Value, 2019–2029

Table 155    Algeria Infection Surveillance Solutions Market Size, By Value (USD Million), 2019–2029

Table 156    Algeria Infection Surveillance Solutions Market Size, By Offering, By Value, 2019–2029

Table 157    Algeria Infection Surveillance Solutions Market Size, By Infection Type, By Value, 2019–2029

Table 158    Algeria Infection Surveillance Solutions Market Size, By End Use, By Value, 2019–2029

Table 159    Rest of MEA Infection Surveillance Solutions Market Size, By Value (USD Million), 2019–2029

Table 160    Rest of MEA Infection Surveillance Solutions Market Size, By Offering, By Value, 2019–2029

Table 161    Rest of MEA Infection Surveillance Solutions Market Size, By Infection Type, By Value, 2019–2029

Table 162    Rest of MEA Infection Surveillance Solutions Market Size, By End Use, By Value, 2019–2029

Table 163    Citigroup Inc. Company Overview

Table 164    Citigroup Inc. Financial Overview

Table 165    JPMorgan Chase & Co. Company Overview

Table 166    JPMorgan Chase & Co. Financial Overview

Table 167    Wells Fargo & Company Overview

Table 168    Wells Fargo & Company Financial Overview

Table 169    Bank of America Corporation Company Overview

Table 170    Bank of America Corporation Financial Overview

Table 171    American Express Company Overview

Table 172    American Express Company Financial Overview

Table 173    HSBC Holdings plc Company Overview

Table 174    HSBC Holdings plc Financial Overview

Table 175    Industrial and Commercial Bank of China Company Overview

Table 176    Industrial and Commercial Bank of China Financial Overview

Table 177    U.S. Bancorp Company Overview

Table 178    U.S. Bancorp Financial Overview

Table 179    BNP Paribas, Company Overview

Table 180    BNP Paribas, Financial Overview

Table 181    TD Bank, N.A. Company Overview

Table 182    TD Bank, N.A. Financial Overview

Market Segmentation

No data available
No data available

To request a free sample copy of this report, please complete the form below.

We value your investment and offer free customization with every report to fulfil your exact research needs.

This website is secure and your personal details are safe.

Frequently Asked Questions (FAQs):

Ans: Major factors driving the growth of Global Infection Surveillance Solutions Market include growing adoption of antimicrobial stewardship programs and thriving healthcare IT segment.
Ans: Global Infection Surveillance Solutions Market size was estimated at USD 469.91 Million in 2022.
Ans: The software segment is expected to hold a higher market share in the Global Infection Surveillance Solutions Market by offering.
Ans: The surgical site infections (SSI) segment is expected to hold the highest market share in the Global Infection Surveillance Solutions Market by infection type.
Ans: Key players in Global Infection Surveillance Solutions Market include Cerner Corporation, Epic Systems Corporation, VigiLanz Corporation, Becton, Dickinson and Company, Premier Inc., DEB Group Ltd, RL Solutions, Baxter International Inc. (ICNet International), Gojo Industries Inc., and IBM Corporation (Truven Health Analytics).